Wednesday, April 2, 2025 4/2/2025

Clinical Trials Network: Pacific Northwest Node

Award Number: UG1DA013714
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

Clinical Trials Network: Pacific Northwest Node - PROJECT SUMMARY/ABSTRACT The evolving landscape of opioids, methamphetamine, legalized cannabis, and effects of structural racism and stigma have led to prioritization of several themes in addiction treatment research. Marginalized and under- represented minority populations continue to disproportionately bear the burden of SUDs and co-occurring mental illness, and their voices must be included in research foci, workforce training, and relevant dissemination. Innovations in MOUD treatment, overdose prevention, harm reduction strategies, and novel therapeutics and technologies are needed to address the leading challenges in SUD treatment. The NIDA National Drug Abuse Treatment Clinical Trials Network (CTN) has prioritized these challenges. To contribute to the CTN’s objectives and research priorities, the Pacific Northwest (PNW) Node proposes the following Specific Aims: 1) Increase capacity of the PNW Node research team to ensure inclusion of populations experiencing structural inequities by expanding investigators with practical and clinical expertise in opioid, methamphetamine, and other drugs of abuse; substance use impacts on youth and families; emerging behavioral, neuromodulation and pharmacologic treatments; SUD treatment access in primary care (PC); and harm reduction strategies in community settings serving stigmatized, BIPOC, and minoritized or under-served populations. 2) Expand scope, population, diversity, and focus of PNW Node’s roster of research, practice, and dissemination settings by including new settings for SUD treatment and PC, and partnerships with individuals and organizations focusing on drug and alcohol related policy in the Pacific Northwest. This will strengthen our continued focus on structural inequity, including BIPOC; people living in rural areas; youth and families; people with lived experience; individuals with co-occurring substance use and mental or physical health disorders; and gender and sexual minorities. 3) Design and conduct pragmatic, comparative effectiveness, implementation, data science, and other types of studies that evaluate novel behavioral, pharmacological, and technology-based treatments for opioids, methamphetamine, and cannabis. Studies will be informed bi-directionally by SUD researchers, clinicians, primary and acute care providers and our community advisory board, and enhanced where appropriate by use of Electronic Health Records, with emphasis on BIPOC study recruitment. 4) Provide dissemination, workforce training, and technical assistance to affiliated SUD and healthcare providers, researchers, and the public about SUDs, medication treatments, and behavioral interventions integrated into settings serving people who use substances. We will use strategic cross-node collaborations and UW/WSU training, technical assistance and dissemination programs to complete this work.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $791,361 )
2025	2025	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	001	24	1/17/2025	COMPETING CONTINUATION	$791,361
2025	2025	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	002	24	2/21/2025	COMPETING CONTINUATION	$0
2025	2024	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	000	23	1/15/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $791,361

Issue Date FY: 2024 ( Subtotal = $973,342 )
2024	2024	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	001	23	2/28/2024	NON-COMPETING CONTINUATION	$1,494,232
2024	2024	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	002	23	4/24/2024	NON-COMPETING CONTINUATION	$166,025
2024	2024	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	003	23	8/12/2024	NON-COMPETING CONTINUATION	$0
2024	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	000	18	10/1/2023	SUPPLEMENT FOR EXPANSION	-$686,915
														Subtotal = $973,342

Issue Date FY: 2023 ( Subtotal = $1 )
2023	2023	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	001	22	4/7/2023	NON-COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	002	22	8/9/2023	NON-COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	000	22	2/17/2023	NON-COMPETING CONTINUATION	$1
														Subtotal = $1

Issue Date FY: 2022 ( Subtotal = $653,067 )
2022	2022	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	004	21	9/14/2022	NON-COMPETING CONTINUATION	$0
2022	2022	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	003	21	7/11/2022	NON-COMPETING CONTINUATION	$0
2022	2022	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	002	21	2/28/2022	NON-COMPETING CONTINUATION	$653,067
2022	2020	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	001	19	11/2/2021	COMPETING CONTINUATION	$17
2022	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	000	18	11/2/2021	SUPPLEMENT FOR EXPANSION	-$17
														Subtotal = $653,067

Issue Date FY: 2021 ( Subtotal = $1,962,395 )
2021	2021	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	010	20	5/13/2021	SUPPLEMENT FOR EXPANSION	$270,995
2021	2021	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	011	20	5/21/2021	SUPPLEMENT FOR EXPANSION	$12,431
2021	2021	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	013	20	7/1/2021	NON-COMPETING CONTINUATION	$0
2021	2021	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	012	20	5/26/2021	SUPPLEMENT FOR EXPANSION	$872,923
2021	2021	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	009	20	5/5/2021	NON-COMPETING CONTINUATION	$143,026
2021	2021	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	008	20	3/11/2021	NON-COMPETING CONTINUATION	$663,020
2021	2020	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	006	19	12/2/2020	COMPETING CONTINUATION	$3,099,405
2021	2020	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	007	19	12/21/2020	COMPETING CONTINUATION	$0
2021	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	002	18	12/2/2020	SUPPLEMENT FOR EXPANSION	-$892,228
2021	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	005	18	12/2/2020	SUPPLEMENT FOR EXPANSION	-$5,481
2021	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	001	18	12/2/2020	SUPPLEMENT FOR EXPANSION	-$746,942
2021	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	003	18	12/2/2020	SUPPLEMENT FOR EXPANSION	-$1,091,489
2021	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	000	18	12/2/2020	SUPPLEMENT FOR EXPANSION	-$162,880
2021	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	004	18	12/2/2020	SUPPLEMENT FOR EXPANSION	-$200,385
														Subtotal = $1,962,395

Issue Date FY: 2020 ( Subtotal = $2,776,383 )
2020	2020	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	004	19	7/2/2020	COMPETING CONTINUATION	$0
2020	2020	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	002	19	5/28/2020	SUPPLEMENT FOR EXPANSION	$451,613
2020	2020	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	003	19	6/2/2020	SUPPLEMENT FOR EXPANSION	$1,274,771
2020	2020	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	001	19	5/26/2020	COMPETING CONTINUATION	$1,049,999
2020	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	005	18	7/29/2020	SUPPLEMENT FOR EXPANSION	$0
2020	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	000	18	12/17/2019	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,776,383

Issue Date FY: 2019 ( Subtotal = $4,790,503 ) (Continued on the next page)
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	004	17	4/11/2019	SUPPLEMENT FOR EXPANSION	$27,808
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	002	18	4/4/2019	NON-COMPETING CONTINUATION	$590,187
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	003	17	4/10/2019	SUPPLEMENT FOR EXPANSION	$33,191
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	005	17	4/26/2019	SUPPLEMENT FOR EXPANSION	$96,560
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	011	18	9/18/2019	SUPPLEMENT FOR EXPANSION	$892,228
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	007	18	5/13/2019	SUPPLEMENT FOR EXPANSION	$5,481
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	001	17	3/8/2019	SUPPLEMENT FOR EXPANSION	$222,216
2019	2019	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Drug Use and Addiction Research Programs	012	18	9/19/2019	SUPPLEMENT FOR EXPANSION	$200,385
Grand Total All Awards = $17,296,565

Page 1 of 2 (69 items)12

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Clinical Trials Network: Pacific Northwest Node

Award Number: UG1DA013714

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer